Page last updated: 2024-09-04

olmesartan and Hepatitis

olmesartan has been researched along with Hepatitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
García-Buey, L; Rubín de Célix, C; Serrano, R1
Ioshii, SO; Précoma, DB; Sturzeneker, MC; Villela Baroncini, LA1

Other Studies

2 other study(ies) available for olmesartan and Hepatitis

ArticleYear
Acute hepatitis due to olmesartan: an uncommon entity.
    Revista espanola de enfermedades digestivas, 2021, Volume: 113, Issue:3

    Topics: Antihypertensive Agents; Blood Pressure; Female; Hepatitis; Humans; Hypertension; Imidazoles; Middle Aged; Tetrazoles

2021
Olmesartan severely weakened the development of NASH in an animal model of hypercholesterolemia.
    Atherosclerosis, 2011, Volume: 216, Issue:1

    Topics: Alanine Transaminase; Angiotensin II Type 1 Receptor Blockers; Animals; Aspartate Aminotransferases; Blood Glucose; Cholesterol, Dietary; Disease Models, Animal; Fatty Liver; Hepatitis; Hypercholesterolemia; Imidazoles; Lipids; Liver; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Rabbits; Tetrazoles; Time Factors

2011